1 active not recruiting, 1 completed, 1 terminated, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Terminated 1, Unknown 1 |
Follow selexipag: new trials by email Literature Review of selexipag trials Research Report on selexipag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag Selexipag, Placebo - Sarcoidosis-associated Pulmonary Hypertension | Phase 2 | Terminated | Actelion | 10 | 2021-02-26 | 2024-05-08 |
| Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension Selexipag - Pulmonary Hypertension, Schistosomiasis | Phase 2 | Unknown | University of Sao Paulo General Hospital | 20 | 2020-10-15 | 2020-10-19 |
| A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension selexipag (Uptravi) - Pulmonary Arterial Hypertension | Phase 2 | Active not recruiting | Actelion | 63 | 2018-07-23 | 2026-09-25 |
| Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis Selexipag, Placebo - Raynaud's Phenomenon Secondary to Systemic Sclerosis | Phase 2 | Completed | Actelion | 74 | 2014-10-31 | 2026-06-03 |
Hypertension, Pulmonary (2) · Pulmonary Arterial Hypertension (2) · Raynaud Disease (1) · Sarcoidosis (1) · Schistosomiasis (1) · Scleroderma, Systemic (1)
Actelion (3) · University of Sao Paulo General Hospital (1)
France (3) · Germany (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Canada (2) · United States (2) · Belarus (1) · China (1) · Hungary (1) · Israel (1) · Italy (1) · Malaysia (1) · Netherlands (1) · Poland (1)
Caio J Fernandes, PHD (1) · Catherine Boisson (1) · Rainer Zimmermann (1) · Ralph Preiss, MD (1)
2018 (1)